Polatuzumab- Rituximab with or without Bendamustine As Second-Line Therapy for Relapsed Refractory Large B-Cell Lymphomas: Single Center ExperienceAriel Perez Perez,Shreya Saxena, Tiba Al Sagheer,Muni Rubens,Talia Zahra,George Nahas,Alex V. Mejia Garcia,Lyle Feinstein, Lisa Reale,Marco Andres Ruiz, Peter L. Citron,Atulya Khosla,Manmeet Ahluwalia,Guenther Koehne,Yuliya P.L. LinharesBlood(2022)引用 0|浏览8暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要